Discover
TELO
Telomir Pharmaceuticals, Inc.
1.30
2 x 0.92
2 x 1.63
bid
ask
+
0.02
1.56%
2 @ 04:00 AM
1.30 +0.00 (0.00%)
| Ytd | -2.26% | |
| 1y | 2.36% |
1.25
day range
1.35
1.05
52 week range
3.10
| Open | 1.28 | Prev Close | 1.28 | Low | 1.25 | High | 1.35 | Mkt Cap | 89.41M |
| Vol | 125.71K | Avg Vol | 153.33K | EPS | -0.29 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | 5.77 | Inst. Own | 6.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 1.30 | 200-d Avg | 1.35 | 1yr Est | 12.15 |
| Income Statement | |||
| Operating Expenses | 1.04M | ||
| Research and Development Expense | 467.80K | ||
| Selling, General and Administrative Expense | 573.54K | ||
| Operating Income | -1.04M | ||
| Interest Expense | 1.25K | ||
| Net Income | -990.95K | ||
| Net Income Common Stock | -990.95K | ||
| Net Income Common Stock (USD) | -990.95K | ||
| Consolidated Income | -990.95K | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -989.69K | ||
| Earning Before Interest & Taxes (USD) | -989.69K | ||
| Weighted Average Shares | 34.38M | ||
| Weighted Average Shares Diluted | 34.38M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.56M | ||
| Cash and Equivalents (USD) | 5.56M | ||
| Current Assets | 5.79M | ||
| Total Assets | 5.79M | ||
| Debt Current | 202.87K | ||
| Total Debt | 202.87K | ||
| Current Liabilities | 827.31K | ||
| Total Liabilities | 827.31K | ||
| Accumulated Retained Earnings (Deficit) | -42.00M | ||
| Shareholders Equity | 4.96M | ||
| Shareholders Equity (USD) | 4.96M | ||
| Total Debt (USD) | 202.87K | ||
| Trade and Non-Trade Payables | 624.44K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 47.35K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.73M | ||
| Issuance (Repayment) of Debt Securities | 47.35K | ||
| Net Cash Flow from Operations | -1.77M | ||
| Share Based Compensation | 39.80K | ||